Total Payments
$27,309
2024 Payments
$7,664
Companies
11
Transactions
32
Medicare Patients
2,122
Medicare Billing
$320,662
Payment Breakdown by Category
Consulting$26,908 (98.5%)
Food & Beverage$401.38 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,908 | 5 | 98.5% |
| Food and Beverage | $401.38 | 27 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SCILEX PHARMACEUTICALS INC. | $26,908 | 5 | $0 (2024) |
| Horizon Pharma plc | $113.75 | 13 | $0 (2017) |
| Organogenesis Inc. | $103.99 | 4 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $54.27 | 2 | $0 (2023) |
| Horizon Therapeutics plc | $28.53 | 2 | $0 (2020) |
| TerSera Therapeutics LLC | $26.74 | 1 | $0 (2019) |
| Fidia Pharma USA Inc. | $17.69 | 1 | $0 (2017) |
| DePuy Synthes Sales Inc. | $16.08 | 1 | $0 (2024) |
| SI-BONE, Inc. | $15.00 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $13.07 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,664 | 3 | SCILEX PHARMACEUTICALS INC. ($7,625) |
| 2023 | $19,418 | 9 | Scilex Pharmaceuticals Inc. ($19,283) |
| 2022 | $12.26 | 1 | Nevro Corp. ($12.26) |
| 2020 | $15.12 | 1 | Horizon Therapeutics plc ($15.12) |
| 2019 | $40.15 | 2 | TerSera Therapeutics LLC ($26.74) |
| 2017 | $159.51 | 16 | Horizon Pharma plc ($113.75) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Consulting Fee | Cash or cash equivalent | $7,625.00 | General |
| Category: Analgesic | ||||||
| 04/24/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device), ORTHOVISC | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Sports Early Intervention | ||||||
| 03/14/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 12/12/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $29.50 | General |
| Category: Wound Care | ||||||
| 09/12/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $31.13 | General |
| Category: Wound Care | ||||||
| 08/16/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $20.58 | General |
| Category: Wound Care | ||||||
| 06/07/2023 | Scilex Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,075.00 | General |
| 05/02/2023 | Scilex Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $4,062.50 | General |
| 04/04/2023 | Scilex Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $3,562.50 | General |
| 03/08/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Pain Management | ||||||
| 02/01/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Pain Management | ||||||
| 01/31/2023 | Scilex Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $10,582.50 | General |
| 05/12/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/07/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: DUEXIS | ||||||
| 09/26/2019 | TerSera Therapeutics LLC | QMIIZ ODT (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: PAIN | ||||||
| 04/04/2019 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: DUEXIS | ||||||
| 11/08/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: DUEXIS | ||||||
| 11/01/2017 | Fidia Pharma USA Inc. | Hymovis (Device) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Osteoarthritis | ||||||
| 10/16/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: DUEXIS | ||||||
| 09/20/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: DUEXIS | ||||||
| 09/05/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: DUEXIS | ||||||
| 08/22/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: DUEXIS | ||||||
| 08/07/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: DUEXIS | ||||||
| 07/05/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: DUEXIS | ||||||
| 06/19/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: DUEXIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 589 | 1,013 | $550,865 | $83,009 |
| 2022 | 14 | 598 | 1,114 | $570,359 | $87,117 |
| 2021 | 12 | 503 | 967 | $531,932 | $88,700 |
| 2020 | 9 | 432 | 858 | $385,943 | $61,837 |
Total Patients
2,122
Total Services
3,952
Medicare Billing
$320,662
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 231 | $96,708 | $17,348 | 17.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 85 | 176 | $98,754 | $15,476 | 15.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 49 | 52 | $68,167 | $9,694 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 90 | $54,495 | $9,540 | 17.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 38 | 41 | $61,348 | $8,965 | 14.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 40 | 104 | $37,591 | $5,415 | 14.4% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 38 | 41 | $51,535 | $4,851 | 9.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 40 | 86 | $27,941 | $4,341 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $22,701 | $3,537 | 15.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 44 | 46 | $10,134 | $1,616 | 15.9% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 36 | 41 | $16,708 | $1,443 | 8.6% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 13 | 13 | $2,864 | $436.80 | 15.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 26 | 67 | $1,920 | $348.82 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 355 | $148,621 | $26,270 | 17.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 87 | 164 | $92,020 | $14,952 | 16.2% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 46 | 46 | $68,830 | $10,231 | 14.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 37 | 38 | $49,814 | $7,255 | 14.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 45 | 139 | $45,161 | $6,860 | 15.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 44 | 133 | $48,073 | $6,733 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 59 | $35,725 | $5,844 | 16.4% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2022 | 29 | 29 | $36,452 | $3,023 | 8.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $11,805 | $1,727 | 14.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $9,017 | $1,276 | 14.1% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 28 | 31 | $6,829 | $1,116 | 16.3% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2022 | 32 | 33 | $13,448 | $1,045 | 7.8% |
About Dr. Michael Shapiro, MD
Dr. Michael Shapiro, MD is a Specialist healthcare provider based in Manhattan Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033200951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Shapiro, MD has received a total of $27,309 in payments from pharmaceutical and medical device companies, with $7,664 received in 2024. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($26,908).
As a Medicare-enrolled provider, Shapiro has provided services to 2,122 Medicare beneficiaries, totaling 3,952 services with total Medicare billing of $320,662. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Manhattan Beach, CA
- Active Since 09/27/2006
- Last Updated 12/07/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033200951
Products in Payments
- ZTLido (Drug) $7,625
- DUEXIS (Drug) $127.07
- Puraply (Medical Supply) $81.21
- Iovera (Device) $54.27
- QMIIZ ODT (Drug) $26.74
- Hymovis (Device) $17.69
- MONOVISC (Device) $16.08
- iFuse Implant (Device) $15.00
- EUFLEXXA (Device) $13.07
- Omnia (Device) $12.26
- VIMOVO (Drug) $11.05
- PENNSAID (Drug) $4.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Manhattan Beach
Dr. Carol Frey, M.d, M.D
Specialist — Payments: $7,002
Specialist $7,002
Dr. Anthony Ahn, M.d, M.D
Specialist — Payments: $3,173
Specialist $3,173
Dr. Keith Feder, M.d, M.D
Specialist — Payments: $3,100
Specialist $3,100
Mr. Gary Vitti, M.s.,A.t.,C, M.S.,A.T.,C
Specialist
Specialist
Dr. Brian Davis, M.d, M.D
Specialist
Specialist
Dr. Nadia Nodoust-Christensen, Md, MD
Specialist
Specialist